Advanced Enzyme Technologies (BOM:540025) LT-Debt-to-Total-Asset : 0.00 (As of Dec. 2023)

View and export this data going back to 2016. Start your Free Trial

What is Advanced Enzyme Technologies LT-Debt-to-Total-Asset?

LT Debt to Total Assets is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. It is calculated as a company's Long-Term Debt & Capital Lease Obligationdivide by its Total Assets. Advanced Enzyme Technologies's long-term debt to total assests ratio for the quarter that ended in Dec. 2023 was 0.00.

Advanced Enzyme Technologies's long-term debt to total assets ratio stayed the same from Dec. 2022 (0.00) to Dec. 2023 (0.00).

Advanced Enzyme Technologies LT-Debt-to-Total-Asset Historical Data

The historical data trend for Advanced Enzyme Technologies's LT-Debt-to-Total-Asset can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Advanced Enzyme Technologies LT-Debt-to-Total-Asset Chart

Advanced Enzyme Technologies Annual Data

Trend

Mar14

Mar15

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

LT-Debt-to-Total-Asset

Get a 7-Day Free Trial

0.01

0.02

Advanced Enzyme Technologies Quarterly Data
	Mar19	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23
LT-Debt-to-Total-Asset	Get a 7-Day Free Trial															-	0.02	-	0.02	-

Advanced Enzyme Technologies LT-Debt-to-Total-Asset Calculation

Advanced Enzyme Technologies's Long-Term Debt to Total Asset Ratio for the fiscal year that ended in Mar. 2023 is calculated as

LT Debt to Total Assets (A: Mar. 2023 )	=	Long-Term Debt & Capital Lease Obligation (A: Mar. 2023 )	/	Total Assets (A: Mar. 2023 )
	=	223.77	/	14218.47
	=	0.02

Advanced Enzyme Technologies's Long-Term Debt to Total Asset Ratio for the quarter that ended in Dec. 2023 is calculated as

LT Debt to Total Assets (Q: Dec. 2023 )	=	Long-Term Debt & Capital Lease Obligation (Q: Dec. 2023 )	/	Total Assets (Q: Dec. 2023 )
	=	0	/	0
	=

Advanced Enzyme Technologies (BOM:540025) LT-Debt-to-Total-Asset Explanation

LT Debt to Total Asset is a measurement representing the percentage of a corporation's assets that are financed with loans and financial obligations lasting more than one year. The ratio provides a general measure of the financial position of a company, including its ability to meet financial requirements for outstanding loans. A year-over-year decrease in this metric would suggest the company is progressively becoming less dependent on debt to grow their business.

Advanced Enzyme Technologies LT-Debt-to-Total-Asset Related Terms

Thank you for viewing the detailed overview of Advanced Enzyme Technologies's LT-Debt-to-Total-Asset provided by GuruFocus.com. Please click on the following links to see related term pages.

Advanced Enzyme Technologies (BOM:540025) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Basic Materials » Chemicals » Advanced Enzyme Technologies Ltd (BOM:540025) » Definitions » LT-Debt-to-Total-Asset

Comparable Companies

Traded in Other Exchanges

ADVENZYMES:India

Address

Near LIC Service Road, Sun Magnetica, A Wing, 5th Floor, Louiswadi, Thane (West), Thane, MH, IND, 400604

Website

https://www.advancedenzymes.com

Advanced Enzyme Technologies Ltd is an Indian company engaged in research activities to manufacture and sell enzymes. The Company operates only in one business segment viz. manufacturing and sales of enzymes. The company offers enzymes for human healthcare and nutrition, animal nutrition, food processing, and non-food processing. Some of the products offered by the company are serratiopeptidase, fungal lipase, papain, hemicellulose, and digegrain, among others. Geographically, the entity operates in India, Europe, the USA, Asia, and other countries, of which a majority of the revenue is derived from India.

Advanced Enzyme Technologies (BOM:540025) Headlines

No Headlines